Your browser doesn't support javascript.
loading
In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.
Rifkin, Robert M; Costello, Caitlin L; Birhiray, Ruemu E; Kambhampati, Suman; Richter, Joshua; Abonour, Rafat; Lee, Hans C; Stokes, Michael; Ren, Kaili; Stull, Dawn Marie; Cherepanov, Dasha; Bogard, Kimberly; Noga, Stephen J; Girnius, Saulius.
Affiliation
  • Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO 80218, USA.
  • Costello CL; Department of Medicine, Division of Blood & Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.
  • Birhiray RE; Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN 46260, USA.
  • Kambhampati S; Kansas City Veterans Affairs Medical Center, Kansas City, MO 64128, USA.
  • Richter J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Abonour R; Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Stokes M; Evidera, Data Analytics, St-Laurent, Quebec, H4T 1V6, Canada.
  • Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA.
  • Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA.
  • Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA.
  • Bogard K; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA.
  • Noga SJ; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA.
  • Girnius S; TriHealth Cancer Institute, Cincinnati, OH 45247, USA.
Future Oncol ; 20(3): 131-143, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37807952

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Future Oncol Year: 2024 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Future Oncol Year: 2024 Document type: Article Affiliation country: Estados Unidos